List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities)

Similar documents
Supplier/ Manufacturer(s) Unit III, Survey No 51, Plot No IDA, Jeedimetla, Hyderabad, Telangana, Hetero labs limited

Sulfamethoxazole/Trimethoprim 400mg/80mg Tablets (Micro Labs Ltd), HA598. WHOPAR part 5 July 2017 LABELLING

SCIENTIFIC DISCUSSION

M/s. Hetero Labs Ltd.

SCIENTIFIC DISCUSSION. Darunavir

SCIENTIFIC DISCUSSION

PATIENT INFORMATION LEAFLET

Mylan Laboratories Limited F-4 & F-12, Malegaon MIDC, Sinnar Nashik Maharashtra State, India

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION. Efavirenz

SCIENTIFIC DISCUSSION

Nevirapine 200mg Tablet WHOPAR part 3 May 2005 Updated: May 2016 PACKAGE LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET


Redefining The Math. The less the better WEEKS. Daclatasvir 60 mg Tablet K S

Generic HCV DAAs. Economics and sustainability. Dr. Andrew Hill Pharmacology and Therapeutics University of Liverpool, UK

WHOPAR. SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION. Antimycobacterial (J04AC01).

PACKAGE LEAFLET. Lamivudine/Zidovudine 150/300 mg Tablets WHOPAR part 3 04/2009, version 1.0 Section 6 updated: June 2017 (Mylan Lab.

Modern Times Helpline Pharma

Invitation to Manufacturers 16 August 2017

PATIENT INFORMATION LEAFLET

List Of ARV Pharmaceutical Products classified according to the Global Fund Quality Assurance Policy

SCIENTIFIC DISCUSSION

List Of ARV Pharmaceutical Products classified according to the Global Fund Quality Assurance Policy

List Of ARV Pharmaceutical Products classified according to the Global Fund Quality Assurance Policy

LETTERS FOR ISSUE ON

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION

PATIENT INFORMATION LEAFLET

Cost effectiveness of sofosbuvir and ledipasvir (Harvoni ) in combination with other medicinal products for the treatment of hepatitis C infection

PATIENT INFORMATION LEAFLET

SCIENTIFIC DISCUSSION

Abacavir (as sulfate) 300 mg tablets WHOPAR part 6 May 2016 (Hetero Labs Ltd), HA575

Pack Size: 20 mg: Blister Pack of 150 tablets (15 x 10 Unit-dose) 40 mg/80 mg: Blister Pack of 250 tablets (25 x 10 Unit-dose)

LETTERS FOR ISSUE ON

SCIENTIFIC DISCUSSION

LETTERS FOR ISSUE ON

Paediatric ARV Procurement Working Group Progress Review at 31 December 2015

Copenhagen, Denmark September 2014

Efavirenz/Emtricitabine/ WHOPAR part 6 August 2011 Tenofovir disoproxil fumarate 600mg/200mg/300mg Tablets (Matrix Lab.

Drug Development by Government Pharmaceutical Organization. Dr. Rachaneekorn Jevprasesphant The Government Pharmaceutical Organization (GPO) Thailand

Case 3:15-cv PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )

Lamivudine Tablets 150 mg (Macleods Pharmaceuticals Ltd), HA424. WHOPAR Part 5 05/2011, version 1.0 LABELLING. Page 1 of 8

REGULATORY PERSPECTIVE. Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore

PATIENT INFORMATION LEAFLET

SCIENTIFIC DISCUSSION

John Amis/AP Images for AIDS. Healthcare Foundation

Q&A for submission of applications for prequalification of Zinc Sulfate tablets and Zinc Sulfate oral liquid (solution)

SCIENTIFIC DISCUSSION

Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/03/2016 to 29/04/2016

14 th SEC- Gastroenterology& Hepatology held on at CDSCO (HQ), FDA Bhawan, Kotla road, NewDelhi

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

Artemether 20mg/lumefantrine 120mg WHOPAR part 5 12/2011 Dispersible tablets (Novartis Pharma AG), MA069 LABELLING. Page 1 of 6

The Soft Gel Specialist

SCIENTIFIC DISCUSSION. Lopinavir and Ritonavir 200 mg/50 mg Tablets * Name of the Finished Pharmaceutical Product:

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

Public Assessment Report. Scientific discussion. Carvedilol Aurobindo 6.25 mg and 25 mg, film-coated tablets (carvedilol) NL/H/2609/ /MR

New Exception Status Benefits

Decentralised Procedure. Public Assessment Report. Memantin AbZ 10 mg/20 mg Filmtabletten ; Starterpack

PATIENT INFORMATION LEAFLET

LETTERS FOR ISSUE ON

Update on progress of MPP sublicensees

File no./drug Name Name of firm/ Institute Recommendations. New Drugs Division

Please see the attached drug alert for onward transmission as below.

PATIENT INFORMATION LEAFLET

Unigel TM Case Study: Extending Soft Gelatin Capsule Benefits to Novel Fixed Dose Combinations

Public Assessment Report. Scientific discussion. Mogilarta. (Telmisartan and hydrochlorothiazide) DK/H/2306/ /DC.

LETTERS FOR ISSUE ON

PATIENT INFORMATION LEAFLET

THE MEDICINES PATENT POOL APPROACH TO SCALE UP ACCESS TO HIV AND HCV TREATMENT. Esteban Burrone Head of Policy

PATIENT INFORMATION LEAFLET

Lamivudine 150 mg & Zidovudine 300 mg tablets WHOPAR Part 3 August 2007 (Strides Shasun Ltd), HA291 Section 6 updated: May 2016 PACKAGE LEAFLET

PATIENT INFORMATION LEAFLET

RESULTS AND DISCUSSION

PATIENT INFORMATION LEAFLET

Information to be included with an application for inclusion, change or deletion of a medicine in the WHO Model List of Essential Medicines:

PATIENT INFORMATION LEAFLET

Procurement, selection, prequalification, pricing and monitoring of medicines

Tamsulosin Hydrochloride 0.4 mg Capsule

Welcome to Galenicum! APRIL, 2013

Free Trial Future Generics Database

TODAY LETTER DATED

PDF of Trial CTRI Website URL -

Products to which COPP granted

Public Assessment Report. Scientific discussion. Bloxazoc 25 mg, 50 mg, 100 mg and 200 mg prolonged-release tablets Metoprolol succinate

WHO PUBLIC INSPECTION REPORT (WHOPIR) Contract Research Organization

Priority essential medicines: identifying products. Dr Suzanne Hill September 2010

Lekpharm JLLC, , Minskaya region, Logoysk, Minskaya str. 2a. Lekpharm JLLC, , Minskaya region, Logoysk, Minskaya str.

Procurement policies and requirements

Information to be included with an application for inclusion, change or deletion of a medicine in the WHO Model List of Essential Medicines:

SCIENTIFIC DISCUSSION. AkuriT-3 Tablets*

Public Assessment Report. Scientific discussion. Pregabalin Orion (pregabalin) SE/H/1440/01-07/DC

Public Assessment Report. Scientific discussion. Tadalafil 1A Pharma 2.5 mg, 5 mg, 10 mg and 20 mg, film-coated tablets.

Public Assessment Report. Scientific discussion. Aktiprol 50 mg, 100 mg, 200 mg and 400 mg tablets. (Amisulpride) DK/H/2386/ /DC

Transcription:

Edition: Version 11-19th of July 2018 List of A & B Products List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities) As from the version 4, please note that we consider under Supplier / Manufacturer : Marketing authorization/ product authorization or license holder Manufacturing Site: The Site responsible for the release of the FPP Ref. No International Nonproprietary name Strength/ Dose Dosage form Supplier/ Manufacturer(s) Global Fund QA Standard WHO Prequalificatio n/ SRA Manufacturing site Country Material Pack 18 Daclatasvir 30mg Tablet BMS Pharma UK A-B Yes, na Batch release:bms Italy Blister 28 (2x14's)

Daclatasvir (dihydrochloride) 30mg Tablet A-B HP007 Vernon, na, 47620, Manufacturing, Daclatasvir (dihydrochloride) 60mg Tablet A-B HP008 Vernon, na, 47620, Manufacturing, 19 Daclatasvir 60mg Tablet BMS Pharma UK A-B Yes, na Batch release:bms Italy Blister 28 (2x14's) Daclatasvir (dihydrochloride) 90mg Tablet B EMEA/H/C/0037 68 Vernon, na, 47620, Manufacturing, 1 Entecavir 0.5 mg Tablet Hetero labs Limited A-B HP005 ANDA 205740 HDPE Bottle ; Blister pack 30, 90 ; 10, 10*10

1 Entecavir 1.0 mg Tablet Hetero labs Limited A-B HP006 ANDA 205740 HDPE Bottle ; Blister pack 30, 90 ; 10, 10*8 Sofosbuvir 400 mg Tablet Ltd A HP001 F4 & F12 Malegaon MIDC, Sinnar, Nashik District, Maharashtra, 422 113, HDPE Bottle -White or Blue 28 Sofosbuvir 400 mg Tablet Cipla Ltd A HP004 Sofosbuvir 400 mg Tablet Hetero labs Limited A HP002 Cipla, Unit 2, Plot A- 42 MIDC Industrial Area, Patalganga, Raigad District, Maharashtra, 410 220, Blister, Alu- PVC/PE/PVdC Bottle,HDPE 14x2; 28x1;84x1 HDPE Bottle 28

Edition: Version 11-19th of July 2018 List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities) List of ( Expert Review Panel) Products which are permitted for time limited procurement Ref. No International Nonproprietary name Strength/ Dose Dosage form Supplier/ Manufacturer(s) Global Fund QA Standard Period Validity for Review Manufacturing site Country Material Pack Sofosbuvir 400 mg Tablet European Egyptian Pharm. Ind. 19-06-18 Cairo Desert Road KM.25, El Manshia Alex, Amriya, Alexandria, Egypt Egypt HDPE Bottle 28 Sofosbuvir 400 mg Tablet Strides Shasun Ltd 27-08-18 Strides Shasun ltd- 36/7, Suragajakkanahalli Indlavadi Cross, Anekal Taluk Bangalore-562 106 HDPE Bottle 28 Daclatasvir 30 mg Tablet Limited F- 4 & F-12, MIDC, Malegaon, Sinnar, Nashik - 422 113 Maharashtra 28; 10x1 Daclatasvir 30 mg Tablet Cipla Ltd Plot No. A-42 (Unit II), MIDC, Patalganga, District - Raigad, Maharashtra, Pin code: 410 220 28; 14x2 Edition: Version 11, 19th of July-2018 List of hepatitis drugs

Daclatasvir 30 mg Tablet Hetero Lab Ltd 17-04-2019 Unit- V, TSIIC Formulation SEZ, Sy No. 439, 440, 441 & 458, Polepally Village, Jadcherla Mandal, Mahaboobnagar District, Telangana HDPE Bottle 28 Daclatasvir 60 mg Tablet Limited F- 4 & F-12, MIDC, Malegaon, Sinnar, Nashik - 422 113 Maharashtra 28; 10x1 Daclatasvir 60 mg Tablet Cipla Ltd Plot No. A-42 (Unit II), MIDC, Patalganga, District - Raigad, Maharashtra, Pin code: 410 220 28; 14x2 Daclatasvir 60 mg Tablet Hetero Lab Ltd 17-04-2019 Hetero Labs Limited Unit- V, TSIIC Formulation SEZ, Sy No. 439, 440, 441 & 458, Polepally Village, Jadcherla Mandal, Mahaboobnagar District, Telangana HDPE Bottle 28 Ledipasvir+ sofosbuvir 90 mg+ 400 mg Tablet FDC Cipla Ltd 09-07-2019 KRS Gardens Tablet Block 36/7, Suragajakkanahalli, Indlavadi cross, Anekal Taluk Bangalore 562 106 HDPE Bottle 14 s, 15 s, 30 s or 28 s End of products list Edition: Version 11, 19th of July-2018 List of hepatitis drugs